Cultural Variation in the Responses to Pharmacotherapy and the "Non-Specific" Factors which May Affect This or "We Know All the Answers—It Is the Questions that We Do Not Know"
Restricted accessOtherFirst published online July, 1980
Cultural Variation in the Responses to Pharmacotherapy and the "Non-Specific" Factors which May Affect This or "We Know All the Answers—It Is the Questions that We Do Not Know"
Anderson, K. et al. 1974. The inter-rater reliability of scales for rating symptoms and side-effects in schizophrenic patients during a drug trial. A multicenter multidimensional study of some new longacting neuroleptic drugs . Acta Psychiatrica Scandinavica Supplement249: 38.
2.
Ban, T.A.et al.1971. Doxepin in the treatment of psychoneurotic patients; a comparison between two clinical settings. International Journal of Clinical Pharmacology, Therapy andToxicology2: 236.
3.
Boszormenyi, Z.1974. Contributions to some questions of the transcultural psychopharmacology . Confina Psychiatrica14 (1971): 226-32. Reviewed in Transcultural Psychiatric Research Review11: 28.
4.
Brehmer, B. et al. 1970. A cross-cultural comparison of cognitive conflict. Journal of Cross-Cultural Psychology1: 5.
5.
Brody, H.1974. Inishkillane. Change and Decline in the West of Ireland . New York: Schocken Books .
6.
Burdock, E.I. et al. Problems and profits of cross-national collaborative studies, VIII. Diseases of the Nervous System35: 31.
7.
Carstairs, G.M.1965. Cultural elements in the response to treatment . In A. V. S. De Reuck and R. Porter, eds., Transcultural Psychiatry. A Ciba Foundation Symposium. London: J. & A. Churchill, Ltd.
8.
Ciccolunghi, S.N.1975. Personal communication.
9.
Collard, J.1962. Drug responses in different ethnic groups. Journal ofNeuropsychiatry3: 114.
10.
Dancoff, J.1975. Ethnic germ warfare. New Times5: 14.
11.
Davies, B. et al. 1975. Controlled trials of Doxepine (Sinequan) in Melbourne and Hong Kong. In T. M. Itil , ed., Transcultural Neuropsychopharmacology. Istanbul: Bozak Publishing Co.
12.
Denber, H.C.B. et al. 1961. Wirkungunterschiede von Butyrylperazine bei einer amerikanischen und deutschen Patientengruppe. Neuropsychopharmakologie, 2. Symposium, Nurnberg, 1961. Medicina Experimentalis5 (1961): 271-79.
13.
Efron, D.H. et al. 1967. Ethnopharmacologic Search for Psychoactive Drugs. Proceedings of a Symposium held in San Francisco, California. New York: Raven.
14.
Friedhoff, A.J.1967. Biochemical effects of experimental diets. Journal of Psychiatric Research5: 265.
15.
Furst, P.T.1972. Flesh of the Gods. The Ritual Use of Hallucinogens . New York: Praeger.
16.
Goldberg, S.C. et al. 1966. Sex and race differences in response to drug treatment among schizophrenics. Psychopharmacology9: 31.
17.
Gross, F.1976. Advice to advisers?European Journal of Clinical Pharmacology9: 467.
18.
Hollister, L.E.1975. Are side effects subject to transcultural influences ? In T. M. Itil, ed., Transcultural Neuropsychopharmacology. Istanbul: Bozak Publishing Co.
19.
Itil, T. M., ed. 1975. Transcultural Neuropsychopharmacology. Selected Contributions from the Symposiums on Transcultural Neuropsychopharmacology in Istanbul and in Puerto Rico. Istanbul: Bozak Publishing Co.
20.
Joyce, C.R.B.1962. Differences between physicians as revealed by clinical trials. Proceedings of the Royal Society of Medicine55: 776.
21.
—. 1978. Non-pharmacological mechanisms of drug action. In J. Fabre, ed., Thérapeutique Médicale. Paris: Flammarion Médecine.
22.
—. 1979. The point is this ... the result was that... Rehabilitation medicine. In press.
23.
— et al. 1969. Quantitative study of doctor-patient communication . Quarterly Journal of Medicine38: 183.
24.
Kellaway, G.S.M. et al. 1975. Non-compliance and errors of drug administration in patients discharged from acute medical. wards. New Zealand Medical Journal81: 508.
25.
Keskiner, A. et al. 1975. Butaperazine in the treatment of acute and chronic schizophrenic populations—a collaborative study. In T. M. Itil, ed., Transcaltural Neuropsychopharmacology . Istanbul: Bozak Publishing Co.
26.
Lemon, N.F.1976. Some cross-cultural perspectives on social psychology . Bulletin of the British Psychological Society29: 65.
27.
Loudon, J.B.1965. Social aspects of ideas about treatment. In A. V. S. De Reuck and R. Porter, eds., Transcultural Psychiatry. A Ciba Foundation Symposium. London: J. & A. Churchill, Ltd.
28.
Lurie, H.J. and Lawrence, G.L.1972. Communication problems between rural Mexican-American patients and their physicians: description of a solution. American Journal of Orthopsychiatry42: 777.
29.
Lynn, R.1973. National differences in anxiety and the consumption of caffeine. British Journal of Social and Clinical Psychology12: 92.
30.
Malm, U. et al. 1974. Environmental factors and drug trials. 1. Staff attitudes to drug trials at psychiatric hospitals. A multicenter multidimensional study of some new long-acting neuroleptic drugs. Acta Psychiatrica Scandinavica Supplement249: 7.
31.
Margetts, E.L.1965. Methods of psychiatric research in Africa. In A. V. S. De Reuck and R. Porter, eds., Transcultural Psychiatry. A Ciba Foundation Symposium. London: J. & A. Churchill, Ltd.
32.
Murphy, H.B.M.1969. Ethnic variations in drug response. Transcultural Psychiatric Research Review6: 5.
33.
—. 1972. Psychopharmacologie et variations ethnoculturelles . Confrontations Psychiatriques9: 163.
34.
—. 1976. Personal communication.
35.
Newberne, P.M.1975. Influence on pharmacological experiments of chemicals and other factors in diets of laboratory animals. Federal Proceedings34: 209.
36.
Perris, C.1974. A multicenter multidimension study of some new longacting neuroleptic drugs. General Introduction. Acta Psychiatrica Scandinavica Supplement249: 5.
37.
Pfeiffer, W.M. and Gebelein, E.1969. Cited by Murphy, 1972.
38.
Pinto, O. De S. et al. 1973. A comparison of two different Ludiomil dose levels. In P. Kielholz, ed., Masked Depression. Berne: Huber .
39.
Raskin, A. et al. 1975. Antidepressants in black and white inpatients . Archives of General Psychiatry32: 643.
40.
Rogan, E.N. et al. 1973. A worldwide transcultural survey of diagnostic, treatment and etiological approaches in schizophrenia. Transcultural Psychiatric Research Review10: 107.
41.
Sackett, D.L. and Haynes, R.B.1976. Compliance with Therapeutic Regimens. Baltimore: Johns Hopkins University Press.
42.
Slater, P.E. and Kastenbaum, R.1966. Paradoxical reactions to drugs: some personality and ethnic correlates. Journal of the American Geriatric Society14: 1016.
43.
Stewart, T.R. et al. 1975. New Analyses: application of judgment theory to physicians' judgments of drug effects. In K. R. Hammond and C. R. B. Joyce, eds., Psychoactive drugs and social judgment. Theory and Research. New York: Wiley and Sons.
44.
Uhlenhuth, E.H. et al. 1959. The symptomatic relief of anxiety with Meprobamate, Phenobarbital and placebo. American Journal of Psychiatry115: 905.
45.
Welner, J.1972. A multinational multicenter, double-blind trial of a new antidepressant (CIBA 34-276-Ba). In P. Kielholz , ed., Depressive Illness: Diagnosis, Assessment, Treatment . Baltimore: Williams & Wilkins .
46.
Winston, A. et al. 1972. Inpatient treatment of blacks and whites . Archives of General Psychiatry26: 405.
